Use quotation marks("") to search for exact phrase or group of words
e.g. "breakbone fever"
Use "OR" to get either results
Placing "OR" in between your keywords gives you more results
e.g. dengue OR "breakbone fever"
Use "NOT" to exclude words
e.g. health care service NOT in manila
A Phase 3 Multi-Center International, Randomized, Active-Controlled Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost with UB-612 Vaccine
Global Study on the Clinical Detection Performance and Usefulness of Novel Coronavirus Rapid Diagnostic Kit
The agreement rate between the test results of RT-PCR test and the Rapid Antigen Test.
To verify that the ESPLINE SARS-CoV-2 (Fuji Rebio, Co. Ltd, Japan) has comparable clinical detection performance to that of RT-PCR, an existing nucleic acid detection test. The following concerns with consideration of the usefulness of the kit as a routine test due to its versatility will be addressed by testing nasopharyngeal swab specimens from participants suspected of the novel coronavirus, SARS-CoV-2 infection.
A Randomized, Observer-blind, Phase 2/3 Adaptive Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Dose Levels of Ad26.COV2.S Administered as a One- or Two-dose Regimen in Healthy Adolescents From 12 to 17 Years Inclusive
Coronavirus Disease-2019 (COVID-19) Prevention
The Prevalence of Renal Hyperparathyroidism among Dialysis-Requiring Patients
The primary outcome in this study is the prevalence of Renal hyperparathyroidism.
Local prevalence of Renal hyperparathyroidism and correlation of intact Parathyroid hormone (iPTH) levels, Vitamin D, serum Calcium and serum Phosphorus with the risk factors identified among dialysis-requiring patients.
A Randomized, Double-Blind, International Multi-Center Clinical Study to Investigate Efficacy and Safety of Lianhua Qingwen Capsules Compared to Placebo and Combined with Standard of Care (SOC) in Adult Patients with Mild to Moderate COVID-19
The study aims to evaluate the clinical efficacy, safety, and economy of LHQW in the treatment of adult patients with mild to moderate COVID-19.
A phase III, randomized, observer-blind, active-controlled, parallel-group, multi-center study to evaluate immunogenicity and safety of a preventive COVID-19 vaccine EuCorVac-19 in healthy adults aged 18 years and older
Preventive intervention (vaccine) for COVID-19 infection
Social media intervention in patients with psoriasis
EFFECTS ON POST-OPERATIVE PAIN REDUCTION IN CESAREAN SECTIONS (LOW MIDLINE INCISION) WITH THE USE OF CRYOTHERAPY: A RANDOMIZED CONTROL TRIAL
This study aims to determine the post-operative pain reduction by adding cryotherapy to the standard postoperative pain management in cesarean sections (low midline incision) among patients in Corazon Locsin Montelibano Memorial Regional Hospital.
The information derived from this research shall form part of an integral data base that could help guide future researches with the use of adding a non-pharmacologic treatment and it’s benefits in obstetric postoperative pain management.
EVALUATION OF FINE NEEDLE BIOPSY (FNB) FOR EUS GUIDED TISSUE ACQUISITION OF PANCREATIC MASSES TO NEGATE THE NEED FOR RAPID ON-SITE EVALUATION: A RANDOMIZED CONTROL TRIAL
Diagnostic yield of EUS FNA with ROSE versus EUS FNB without ROSE for solid pancreatic masses.
Inclusion Criteria• Age more than 18 years old• Patients requiring endoscopic ultrasound and tissue sampling of solid lesions greater than 1cm diameter in the pancreas that are visualized and within the reach of EUS FNA
Endoscopic ultrasound (EUS) guided fine needle aspiration (FNA) or biopsy (FNB) of pancreatic tumors.
Rapid onsite evaluation (ROSE) of biopsy/aspiration samples
A Phase 2, Randomized, Double-blind, Placebo-controlled, Double-dummy, Multicenter Trial Assessing the Efficacy and Safety of Two Dose Regimens of JNJ-64281802 for the Prevention of Dengue Infection
The purpose of this study is to evaluate the prophylactic effect of JNJ-64281802 with respect to the prevention of laboratory-confirmed dengue virus (DENV) infection up to last day of dosing among participants who have no evidence of current DENV infection at baseline.